BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• 

  BioForest

  Engineers Invent Programming Language to Build Synthetic DNA, University of Washington Study

  October 1, 2013

   · 

  1 min read
• 

  Menopausal Women May Still Conceive, St. Mariana University School of Medicine Study

  October 1, 2013

   · 

  1 min read
• 

  Resveratrol, Found in Red Wine, Worsens MS-Like Symptoms, Louisiana State University Study

  October 1, 2013

   · 

  1 min read
• Business

  Cydan Expands Initial Financing to $26 Million; Additional Money Validates Unique Orphan Drug Accelerator Model

  October 1, 2013

   · 

  2 min read
• Business

  Merck & Co. Updates Plans for Headquarters Move in New Jersey

  October 1, 2013

   · 

  1 min read
• Business

  Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Cancer Center, the Rockefeller University and Weill Cornell Medical College, and Partnership Formed With Takeda Pharmaceutical Co. Ltd.

  October 1, 2013

   · 

  12 min read
• Job Trends

  Merck & Co., Inc. Slashes 8,500 Jobs to Save $2.5 Billion

  October 1, 2013

   · 

  1 min read
• Genetown

  PHT Clinical Science and Consulting Expands to Meet Growing eClinical Demand for Clinical Outcomes Assessment (COA) Expertise

  October 1, 2013

   · 

  1 min read
• Deals

  Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Acquires Geron Corporation’s Embryonic Stem Cell Assets

  October 1, 2013

   · 

  1 min read
• Teva Pharmaceutical Industries Limited Announces Launch of Generic Zemplar® in the United States

  October 1, 2013

   · 

  1 min read